Literature DB >> 1449128

Hepatotoxicity of nonsteroidal anti-inflammatory drugs.

M Rabinovitz1, D H Van Thiel.   

Abstract

The steady increase in nonsteroidal anti-inflammatory drug (NSAID) use over the past decade has been associated with an increased awareness of the gastrointestinal complications of these agents. As a result, several reviews on this topic have been published. Associated with the increased recognition of the untoward gastrointestinal consequences of NSAID use has been an increasing awareness of the untoward hepatic consequences of NSAID use. Nonetheless, many physicians either remain unaware of the hepatotoxic potential of NSAIDs or are unsure which agents are either safer or associated with a greater risk for hepatotoxicity. The following is an overview of the hepatotoxicity of NSAIDs that identifies both the type and severity of such reactions, where sufficient data exist to allow such judgements to be made.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449128

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  Aspirin-related hepatotoxicity in a child after liver transplant.

Authors:  T C Chen; K F Ng; L B Jeng; T S Yeh; C M Chen
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database.

Authors:  François Clinard; Catherine Sgro; Marc Bardou; Patrick Hillon; Monique Dumas; Carmen Kreft-Jais; André Escousse; Claire Bonithon-Kopp
Journal:  Eur J Clin Pharmacol       Date:  2004-04-22       Impact factor: 2.953

3.  Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009-2010.

Authors:  Gregory Castelli; Ashley Petrone; Jun Xiang; Carl Shrader; Dana King
Journal:  Am J Cardiovasc Drugs       Date:  2017-06       Impact factor: 3.571

Review 4.  Preventive care in chronic liver disease.

Authors:  T R Riley; J P Smith
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

5.  Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis.

Authors:  Lindsey Tilling; Sue Townsend; Joel David
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

6.  Indomethacin and pancreatic enzymes synergistically damage intestine of rats.

Authors:  R E Kimura; V Arango; J Lloyd-Still
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

7.  Prescribing Pattern of Non-Steroidal Anti-Inflammatory Drugs at the Outpatient Pharmacy Department of a University Teaching Hospital in Nigeria.

Authors:  O Awodele; A O Fadipe; M Adekoya; O O Adeyemi
Journal:  Ghana Med J       Date:  2015-03

8.  Use of over-the-counter analgesics in patients with chronic liver disease: physicians' recommendations.

Authors:  Simona Rossi; David N Assis; Monica Awsare; Mark Brunner; Kevin Skole; Jitha Rai; Jocelyn Andrel; Steven K Herrine; Rajender K Reddy; Victor J Navarro
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.